Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EQUIMETH2: Methadone Titration for Cancer Pain
NCT01793480Phase 3Completed
- Sponsor
- Recordati SpA
- Start
- Jan 2012
- Primary completion
- May 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of methadone in cancer pain (2 arms), sponsored by Recordati SpA. Primary endpoint: Success/failure rate related to methadone switch at Day 4. Started Jan 2012; status: completed.
02
Drugs
methadone
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT01793480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01793480.